Form 8-K EPIRUS Biopharmaceutical For: Aug 07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
EPIRUS Biopharma (EPRS) Misses Q2 EPS by 27c
August 7, 2015 7:09 AM EDTEPIRUS Biopharma (NASDAQ: EPRS) reported Q2 EPS of ($0.65), $0.27 worse than the analyst estimate of ($0.38).
For earnings history and earnings-related data on EPIRUS Biopharma (EPRS) click here.
... More